Research published in the Lancet highlights that iodine radiation is now longer necessary in thyroid cancer care ...

A pioneering study at King's College London, University of Oxford and Guy's and St Thomas' NHS Foundation Trust has ...

In combination with Roche’s PD-L1 blocker Tecentriq, zanzalintinib bested Bayer’s Stivarga. Exelixis is positioning the drug ...

Mark your calendars, place your bets, grease your palms, blink open that third eye, and ready your wishes, my babies ...

A combination featuring Exelixis’ experimental drug zanzalintinib has beaten Bayer’s gastrointestinal cancer med Stivarga in ...

One of the earliest signs of stomach cancer can be pain or discomfort in the stomach area, especially in the morning. You ...